Jan Vermorken
扬·韦尔莫肯
MD, PhD
Emeritus Professor of Oncology; Senior Consultant, Head and Neck Oncology肿瘤学荣誉教授；头颈部肿瘤高级顾问
👥Biography 个人简介
Jan Vermorken is a titan of head and neck cancer oncology, best known for designing and leading the EXTREME trial that established the cetuximab plus platinum/5-FU regimen as the global first-line standard for recurrent/metastatic HNSCC for over a decade. His contributions to HNSCC chemotherapy protocols have saved countless lives worldwide.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
EXTREME Regimen — Cetuximab Plus Platinum/5-FU
Led the pivotal EXTREME phase III trial demonstrating that adding cetuximab to platinum/5-FU chemotherapy significantly improved overall survival in recurrent/metastatic HNSCC, defining the first-line standard of care for over 10 years.
Platinum-Based Induction Chemotherapy Protocols
Pioneered docetaxel-cisplatin-fluorouracil (TPF) induction chemotherapy for locally advanced HNSCC, with TAX 323 trial results showing superior outcomes over PF induction, preserving organ function.
Representative Works 代表性著作
Cetuximab for the treatment of squamous-cell carcinoma of the head and neck (EXTREME trial)
New England Journal of Medicine (2008)
Landmark phase III trial establishing cetuximab plus cisplatin/carboplatin and 5-FU as standard first-line treatment for recurrent/metastatic HNSCC, improving overall survival to 10.1 months.
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer (TAX 323)
New England Journal of Medicine (2007)
Demonstrated TPF induction chemotherapy superior to PF in locally advanced unresectable HNSCC, significantly improving progression-free and overall survival.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Clifton David Fuller
The University of Texas MD Anderson Cancer Center
Barbara Burtness
Yale School of Medicine
Ezra Cohen
UC San Diego Moores Cancer Center
Kevin Harrington
The Royal Marsden NHS Foundation Trust / Institute of Cancer Research
关注 扬·韦尔莫肯 的研究动态
Follow Jan Vermorken's research updates
留下邮箱，当我们发布与 Jan Vermorken（AZ Sint-Augustinus, Antwerp / University of Antwerp）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment